Catalent Pharma Solutions and CTC Bio have entered into a collaboration to provide services to South Korean pharma companies looking to commercialize solid oral dose and controlled release products in the U.S. and Europe. The companies will leverage their expertise in drug delivery technologies to give South Korean customers access to global markets for their products and formulations.   “South Korea is a highly innovative region, developing new products and effective pharmaceutical formulations...